Few health topics have captured social media’s attention quite like GLP-1 medications over the past few years. Running a close second is women’s hormonal health, a subject that spent decades as one of the most under-researched areas in medicine. It is finally getting the attention it deserves! The two conversations are arriving at exactly the right time together.
GLP-1 medications have changed the conversation around metabolic health. More women than ever are exploring these treatments and seeing real results. What tends to get less airtime is how these medications interact with the hormonal systems that shape so much of daily life.
The relationship between GLP-1 treatment and hormone health is not cause for alarm. It is, however, a reason to stay informed, ask thoughtful questions, and pay attention to what your body is communicating throughout treatment. The research points to five areas worth having on your radar.
Changes to your menstrual cycle
Unexpected shifts in fertility
Bone density and nutrition
Thyroid function during weight loss
Mood, energy, and hormones
1. Changes to Your Cycle
Menstrual changes are among the most frequently reported experiences in the GLP-1 community. That's because estrogen, insulin, and body fat are tightly wired together.
A 2023 meta-analysis in BMC Endocrine Disorders found that GLP-1 receptor agonists significantly improved menstrual regularity and natural pregnancy rates in women with PCOS across 11 randomized controlled trials. Better insulin sensitivity can reduce the androgen excess that disrupts ovulation, allowing more regular cycles to return.
Women without PCOS can experience changes, too. Fat tissue is an active endocrine organ that produces estrogen. As body composition shifts during treatment, estrogen output changes, and some women report lighter periods, irregular timing, or temporary disruptions to their usual patterns.
Track your cycle throughout treatment. Log changes in length, flow, and timing, and bring that record to every appointment. Don't filter what you share. A cycle that runs a few days shorter than usual, an unexpected shift in flow, or a week that simply felt off may all be relevant to your provider. Small details help build the full picture, and that picture shapes your care.
2. Unexpected Shifts in Fertility
Improved metabolic health can restore or amplify ovulation in ways that catch women off guard. For women with PCOS, the connection is direct. GLP-1 medications can improve insulin sensitivity, lowering the excess androgen levels that disrupt ovulation in the first place. As insulin resistance falls, ovulatory cycles can resume, sometimes for the first time in years.
The meta-analysis referenced above found that women with PCOS on GLP-1 receptor agonists had a 72% higher natural pregnancy rate compared to controls across 11 randomized controlled trials. A 2024 scoping review in Cureus confirmed these patterns across a broader range of studies, with consistent improvements in menstrual regularity and reproductive outcomes alongside metabolic changes.
A 2024 review in the American Journal of Obstetrics & Gynecology noted that many women previously unable to conceive have experienced unplanned pregnancies while taking GLP-1 medications. Restored ovulation can happen before a woman realizes it has. For anyone not actively trying to get pregnant, a contraception conversation with your provider belongs early in treatment, not after the fact.
GLP-1 medications are not currently recommended during pregnancy. If pregnancy is a goal, discuss timing and any changes to your treatment plan with your provider before making them.
3. Bone Density and Nutrition
GLP-1 therapy is designed to drive meaningful weight loss. Rapid weight loss combined with reduced food intake, however, can place demand on bone health that deserves proactive monitoring.
A 2024 phase 2 trial in eClinicalMedicine, conducted in adults at increased fracture risk, found that 52 weeks of once-weekly GLP-1 therapy was associated with a 2.6% reduction in hip bone mineral density and a 2.1% reduction at the lumbar spine compared to placebo. Researchers observed increased bone resorption with no compensatory increase in bone formation.
Two factors are likely at play. Bone density responds to mechanical load. Less body weight means less daily stress on the skeleton, which can reduce the stimulus for bone maintenance over time. Separately, the appetite suppression that makes GLP-1 treatment effective can leave calcium and vitamin D intake well below what bone remodeling requires, particularly when food volume drops but dietary quality does not improve to compensate.
Three actions make a real difference:
Adequate protein, calcium, and vitamin D intake throughout treatment is essential, not optional. Prioritize nutrient density when food volume is lower
Women approaching or past menopause, or those with a personal history of osteoporosis or osteopenia, should ask their provider about baseline bone density screening before or early in treatment
4. Thyroid Function During Weight Loss
GLP-1 medications are not known to cause thyroid dysfunction. That said, they can trigger thyroid hormone changes through weight loss. For women already on thyroid medication, those changes can require dosage adjustments.
A 2024 review in Biomolecules found that thyroid disease frequently co-occurs with metabolic conditions such as obesity and type 2 diabetes, and that GLP-1 medications can influence TSH levels during treatment. In at least one documented case cited in that review, a patient experienced a significant drop in TSH after beginning GLP-1 therapy and required a 25% reduction in thyroid hormone replacement dosage.
Levothyroxine doses are calibrated to body weight and metabolic state. When significant weight is lost and metabolism shifts, a dose calibrated for a larger body can become too high. The resulting over-medication can produce symptoms including heart palpitations, anxiety, insomnia, and unexplained fatigue, all easy to misattribute to the GLP-1 medication or the weight loss itself.
If you manage a thyroid condition, your prescribing provider needs to know you have started GLP-1 treatment. Routine TSH monitoring during and after significant weight loss is not optional.
5. Mood, Energy, and Hormones
The science is still developing, and the current picture is more encouraging than much of the coverage suggests. A 2025 meta-analysis in JAMA Psychiatry, drawing on data from more than 100,000 participants across randomized controlled trials, found no significant increase in depression or suicidality risk associated with GLP-1 treatment. Participants showed modest improvements in overall well-being. It's worth noting that most trials in this analysis excluded people with pre-existing psychiatric conditions. For women already managing depression, anxiety, or other mental health conditions, the evidence is less established, and closer monitoring alongside a mental health provider is advisable.
Estrogen plays a direct role in regulating the neurological pathways tied to mood, motivation, and emotional stability. As fat decreases and estrogen output from adipose tissue shifts, some women notice periods of low energy, emotional sensitivity, or disrupted sleep, often not from the medication itself but from the hormonal adjustment happening alongside it. For women already in perimenopause, where estrogen is already fluctuating, these effects can be compounded.
Watch for a pattern that tracks with your cycle. Mood changes that worsen in the days before your period and improve afterward may suggest a hormonal pattern rather than a psychiatric one. That distinction is clinically useful, and your provider can only make it if you report the timing alongside the symptom.
Your Experience as Data
Hormonal health is not a side conversation in GLP-1 treatment. It's part of the core picture.
GLP-1 therapy can bring rapid weight loss and a cascade of changes to your body in a short period of time. When that much is shifting at once, it's hard to know what's causing what. Is the fatigue the medication, the hormones, the reduced caloric intake, or something else entirely? That's not a question you should have to answer alone.
Don't wait for symptoms to become problems before raising them. Changes to your cycle, unexpected fatigue, shifts in mood, or questions about bone and thyroid health are all fair game at your next appointment. Your prescribing provider can help you sort out what's hormonal, what's medication-related, what's temporary, and what deserves a closer look. That's exactly what they're there for.
Share everything you observe. It's the most useful thing you can bring to the table.
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription therapies that require evaluation and supervision by a licensed healthcare provider. Individual results may vary, and these medications may not be appropriate for everyone. Consult your doctor to determine if GLP-1 treatment is right for you, and discuss potential risks, benefits, and side effects before beginning or adjusting any treatment.
Leave a Comment
Your email address will not be published. Required fields are marked *